FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 41 filers reported holding FUSION PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $202,891 | +1.4% | 78,035 | +203.6% | 0.00% | -33.3% |
| Q1 2022 | $200,000 | -80.3% | 25,703 | -89.4% | 0.00% | -80.0% |
| Q4 2021 | $1,015,000 | -17.1% | 243,340 | +57.4% | 0.02% | -25.0% |
| Q3 2021 | $1,225,000 | -1.9% | 154,621 | +0.0% | 0.02% | -13.0% |
| Q2 2021 | $1,249,000 | -6.5% | 154,597 | +24.1% | 0.02% | -23.3% |
| Q1 2021 | $1,336,000 | +115.1% | 124,594 | +135.9% | 0.03% | +87.5% |
| Q4 2020 | $621,000 | -32.1% | 52,827 | -30.6% | 0.02% | -46.7% |
| Q3 2020 | $915,000 | -56.3% | 76,093 | -36.6% | 0.03% | -63.9% |
| Q2 2020 | $2,096,000 | – | 120,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,670,516 | $9,140,000 | 2.34% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,982 | $3,887,000 | 1.96% |
| ADAMS STREET PARTNERS LLC | 2,947,809 | $7,340,000 | 1.91% |
| Sio Capital Management, LLC | 260,448 | $649,000 | 0.24% |
| Orbimed Advisors | 3,224,770 | $8,030,000 | 0.15% |
| Artal Group S.A. | 750,000 | $1,868,000 | 0.10% |
| TPG GP A, LLC | 2,551,794 | $6,354,000 | 0.10% |
| Perceptive Advisors | 1,052,445 | $2,621,000 | 0.08% |
| Rock Springs Capital Management LP | 809,854 | $2,017,000 | 0.06% |
| FEDERATED HERMES, INC. | 3,124,100 | $7,779,000 | 0.02% |